Insole Marketing Announcement

Having been issued US Patent 8,122,550 on February 28, 2012, I am now ready to market these innovative insoles.  They provide a treatment adjunct for people with predominantly inner or outer knee joint arthritis.

A person must have foot/ankle and knee laxity as demonstrated on this site in order to benefit from use of these insoles.  The beneficial results of independent studies are reported on   A related site reports the rationale on

The insoles have a wedge configuration that assists in shifting forces across the inner or outer aspect of the knee, depending upon how they are placed in the shoe.